Medable Company

Medable provides a global decentralized trial platform that streamlines design, recruitment, retention, and data quality, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. The platform connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. It is now used by leading biopharma sponsors and clinical research organizations worldwide and has been used for trials in 30+ countries and 26 languages. It was founded in 2015 and is headquartered in Palo Alto, California.
Technology: Developer APIs, Health Care, Medical Device, Messaging, Pharmaceutical
Industry: Clinical Development, Data Processing
Headquarters: Palo Alto, California, United States
Founded Date: 2015-01-01
Employees Number: 251-500
Funding Status: Late Stage Venture
Investors Number: 12
Total Funding: 506638069
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-10-26
Last Funding Type: Series D

Visit Website
info@medable.com
http://twitter.com/MedableInc
Register and Claim Ownership